Organization Profile

You just read:

Welichem and Stiefel, a GSK company, complete the acquisition by Stiefel of the novel anti-inflammatory agent, WBI-1001

News provided by

Welichem Biotech Inc.

Jul 31, 2012, 15:56 ET